Controlled Clinical TrialtaVNS

Combining Celiac and Hepatic Vagus Nerve Neuromodulation Reverses Glucose Intolerance and Improves Glycemic Control in Pre- and Overt-Type 2 Diabetes Mellitus

Waataja JJ, Asp AJ, Billington CJ

Biomedicines · 2023

Key finding

The present study demonstrated that the neuromodulation reversed glucose intolerance in alloxan-treated swine in both pre- and overt stages of T2DM.

Condition
Metabolic
Stimulation
taVNS
Evidence tier
Controlled Clinical Trial
Participants
View on DOI

Cite this study

Waataja, J. J., Asp, A. J., & Billington, C. J. (2023). Combining Celiac and Hepatic Vagus Nerve Neuromodulation Reverses Glucose Intolerance and Improves Glycemic Control in Pre- and Overt-Type 2 Diabetes Mellitus. Biomedicines, 11(9), 2452. https://doi.org/10.3390/biomedicines11092452

Related studies in Metabolic

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.